Evaluating the Efficacy and Safety of 4% 5-Fluorouracil Cream in Patients with Actinic Keratosis: An Expert Opinion
Actinic keratosis is a lesion that develops in sun-exposed areas of the skin and is considered to be a precancerous condition or an early in situ squamous cell carcinoma. Treatment of actinic keratosis is important for reducing skin cancer risk, with treatment choice based on patient-, lesion- and t...
Saved in:
Main Authors: | Eggert Stockfleth (Author), Markus V. Heppt (Author), Nathalie Bégeault (Author), Alain Delarue (Author) |
---|---|
Format: | Book |
Published: |
Medical Journals Sweden,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Severity of Local Skin Reactions with 4% 5-Fluorouracil Plus Emollient versus 4% 5-Fluorouracil Alone in Patients with Actinic Keratosis: A Single-Blind Randomised Trial
by: Eggert Stockfleth, et al.
Published: (2023) -
The Overall Number of Actinic Keratosis Lesions Is Not Predictable by the Number of Visible Lesions: Consequences for Field-Directed Therapies
by: Eggert Stockfleth, MD PhD, et al.
Published: (2022) -
Real-World Experience with Topical 5-Fluorouracil 4% (40 mg/g) Cream for the Treatment of Actinic Keratosis
by: Giulia Briatico, et al.
Published: (2023) -
Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis Treatment
by: Marjan Azin, et al.
Published: (2022) -
Comparative study of actinic keratosis treatment with 3% diclofenac sodium and 5% 5-fluorouracil
by: Majorie Mergen Segatto, et al.
Published: (2013)